Skip to main content

Advertisement

SpringerLink
Log in

Distribution and impact of age in patients with implantable cardioverter-defibrillators regarding early complications and 1-year clinical outcome: results from the German Device Registry

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Background

Patients receiving implantable-cardioverter-defibrillators (ICD) in clinical practice are often older or younger than in clinical trials. Whether older patients benefit from ICD-therapy in a similar way as younger patients is under debate. The objective of this study was to provide real-world data regarding outcomes with respect to age in a large cohort in the German Device Registry.

Methods

Within the registry data from 50 German centers were collected between January 2007 and February 2014.

Results

Our analysis included 3239 ICD patients representing a group of young (28%; group I: < 58 years), intermediate aged (50%; group II: 58–74 years), and elderly patients (22%; group III: 75–92 years). Intergroup comparison of all groups was performed followed by individual comparison vs. group II serving as age-reference group. Procedure-related complications did not differ between all groups. Analysis of the primary endpoint, 1-year all-cause mortality, revealed an increased mortality in the elderly and a decreased mortality in the young cohort vs. the reference group II (group I 2.1%, group II 6.2%, group III 13.2%; p < 0.001). While all-cause rehospitalizations did not differ, we observed a difference in reported device revisions showing more device revisions required in younger patients (group I 8.9%, group II 6.8%, group III 4.0%; p = 0.001).

Conclusions

One-year mortality was doubled in elderly ICD patients probably due to non-cardiac causes. These results further underpin the need for re-evaluating the primary prevention ICD indication in octo- and nonagenarians. Young patients show lower mortality rates but seem to bear higher risk of device-related complications, which highlights the need for improved measures to reduce device-related complications in the young.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. The task force for the Management of Patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology. G Ital Cardiol (Rome). 2016;17(2):108–70.

    Google Scholar 

  2. Daubert JP, Sesselberg HW, Huang DT. Implantable cardioverter-defibrillators for primary prevention: how do the data pertain to the aged? Am J Geriatr Cardiol. 2006;15(2):88–92.

    Article  Google Scholar 

  3. Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, et al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J. 2007 Jul;28(14):1746–9.

    Article  Google Scholar 

  4. Exposito V, Rodriguez-Manero M, Gonzalez-Enriquez S, Arias MA, Sanchez-Gomez JM. Andres La Huerta a, et al. primary prevention implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator in elderly patients: results of a Spanish multicentre study. Europace. 2016;18(8):1203–10.

    Article  Google Scholar 

  5. Kobe J, Andresen D, Maier S, Stellbrink C, Kleemann T, Gonska BD, et al. Complications and 1-year benefit of cardiac resynchronization therapy in patients over 75 years of age - insights from the German device registry. Int J Cardiol. 2017;228:784–9.

    Article  Google Scholar 

  6. Duray G, Richter S, Manegold J, Israel CW, Gronefeld G, Hohnloser SH. Efficacy and safety of ICD therapy in a population of elderly patients treated with optimal background medication. J Interv Card Electrophysiol. 2005 Dec;14(3):169–73.

    Article  Google Scholar 

  7. Santangeli P, Di Biase L, Dello Russo A, Casella M, Bartoletti S, Santarelli P, et al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann Intern Med. 2010;153(9):592–9.

    Article  Google Scholar 

  8. Schwartz PJ, Spazzolini C, Priori SG, Crotti L, Vicentini A, Landolina M, et al. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European long-QT syndrome implantable cardioverter-defibrillator (LQTS ICD) registry. Circulation. 2010 Sep 28;122(13):1272–82.

    Article  Google Scholar 

  9. O'Mahony C, Lambiase PD, Quarta G, Cardona M, Calcagnino M, Tsovolas K, et al. The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy. Heart. 2012;98(2):116–25.

    Article  Google Scholar 

  10. Schinkel AF. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Circ Arrhythm Electrophysiol. 2013;6(3):562–8.

    Article  Google Scholar 

  11. Grimm W, Stula A, Sharkova J, Alter P, Maisch B. Outcomes of elderly recipients of implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2007;30(Suppl 1):S134–8.

    PubMed  Google Scholar 

  12. Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, et al. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J Cardiovasc Electrophysiol. 2007;18(8):833–8.

    Article  Google Scholar 

  13. Groeneveld PW. Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients. LDI Issue Brief. 2008;13(6):1–4.

    PubMed  Google Scholar 

  14. Suleiman M, Goldenberg I, Haim M, Schliamser JE, Boulos M, Ilan M, et al. Clinical characteristics and outcomes of elderly patients treated with an implantable cardioverter-defibrillator or cardiac resynchronization therapy in a real-world setting: data from the Israeli ICD registry. Heart Rhythm. 2014;11(3):435–41.

    Article  Google Scholar 

  15. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006 Jun 20;47(12):2493–7.

    Article  Google Scholar 

  16. Al-Khatib SM, Greiner MA, Peterson ED, Hernandez AF, Schulman KA, Curtis LH. Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol. 2008;1(4):240–9.

    Article  Google Scholar 

  17. Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ, et al. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol. 2012;60(19):1933–9.

    Article  Google Scholar 

  18. Navaneethan SD, Schold JD, Huang H, Nakhoul G, Jolly SE, Arrigain S, et al. Mortality outcomes of patients with chronic kidney disease and chronic obstructive pulmonary disease. Am J Nephrol. 2016;43(1):39–46.

    Article  CAS  Google Scholar 

  19. Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829–41.

    Article  Google Scholar 

  20. Sharma A, de Souza BF, Sun JL, Thomas L, Haffner S, Holman RR, et al. Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: insights from the Nateglinide and valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial. Am Heart J. 2017;186:73–82.

    Article  Google Scholar 

  21. Antiarrhythmics versus Implantable Defibrillators I. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337(22):1576–83.

    Article  Google Scholar 

  22. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, et al. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101(11):1297–302.

    Article  CAS  Google Scholar 

  23. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the cardiac arrest study Hamburg (CASH). Circulation. 2000;102(7):748–54.

    Article  CAS  Google Scholar 

  24. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877–83.

    Article  Google Scholar 

  25. Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S, et al. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the multicenter automatic defibrillator implantation trial II. Circulation. 2010;122(13):1265–71.

    Article  Google Scholar 

  26. Kober L, Thune JJ, Nielsen JC, Haarbo J, Videbaek L, Korup E, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375(13):1221–30.

    Article  Google Scholar 

  27. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37.

    Article  CAS  Google Scholar 

  28. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350(21):2151–8.

    Article  CAS  Google Scholar 

  29. Lawin D, Israel CW, Linde C, Normand C, Dickstein K, Lober C, et al. Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT survey II. Clin Res Cardiol. 2019;109:832–44.

    Article  Google Scholar 

  30. Shimeno K, Yoshiyama T, Abe Y, Akamatsu K, Kagawa S, Matsushita T, et al. The usefulness of right ventriculography to aid anchoring a pacing lead to the right ventricular septum. Europace. 2018;20(7):1154–60.

    Article  Google Scholar 

  31. Bogossian H, Frommeyer G, Hochadel M, Ince H, Spitzer SG, Eckardt L, et al. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator. Less is more! Data from the German device registry. Clin Res Cardiol. 2020;109(7):911–7.

    Article  Google Scholar 

  32. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115(19):2474–80.

    Article  Google Scholar 

  33. Burke MC, Gold MR, Knight BP, Barr CS, Theuns D, Boersma LVA, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and effortless registry. J Am Coll Cardiol. 2015;65(16):1605–15.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University of Duisburg- Essen, Essen, Germany

    Elif Kaya, Tienush Rassaf & Reza Wakili

  2. Stiftung Institut für Herzinfarktforschung Ludwigshafen, Ludwigshafen am Rhein, Germany

    Jochen Senges & Matthias Hochadel

  3. Department of Cardiology II—Electrophysiology, University of Münster, Münster, Germany

    Lars Eckardt

  4. Kardiologie am Evangelisches Krankenhaus Hubertus, Berlin, Germany

    Dietrich Andresen

  5. Department of Cardiology and Internal Medicine, Vivantes Klinikum Am Urban, Berlin, Germany

    Hüseyin Ince

  6. Rostock University Medical Center, Rostock, Germany

    Hüseyin Ince

  7. Institut of Medical Technology, Praxisklinik Herz und Gefäße Dresden and Brandenburg, University of Technology Cottbus-Senftenberg, Senftenberg, Germany

    Stefan G. Spitzer

  8. Department of Cardiology, Klinikum Ludwigshafen, Ludwigshafen, Germany

    Thomas Kleemann

  9. Department of Cardiology, Klinikum Straubing, Straubing, Germany

    Sebastian S. K. Maier

  10. Department of Cardiology, Academic Hospital Villingen, Villingen-Schwenningen, Germany

    Werner Jung

  11. Department of Cardiology, Klinikum Bielefeld, Bielefeld, Germany

    Christoph Stellbrink

Authors
  1. Elif Kaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jochen Senges
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthias Hochadel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lars Eckardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dietrich Andresen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hüseyin Ince
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stefan G. Spitzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Thomas Kleemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sebastian S. K. Maier
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Werner Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Christoph Stellbrink
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Tienush Rassaf
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Reza Wakili
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reza Wakili.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaya, E., Senges, J., Hochadel, M. et al. Distribution and impact of age in patients with implantable cardioverter-defibrillators regarding early complications and 1-year clinical outcome: results from the German Device Registry. J Interv Card Electrophysiol 62, 83–93 (2021). https://doi.org/10.1007/s10840-020-00876-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-020-00876-x

Keywords

Search

Navigation